InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Bernstein Harold. Director active across 1 company, notably Maze Therapeutics, Inc.. In total, 3 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €328k. Activity tracked since 1 June 2026. The latest transaction was filed on 1 June 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations